Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/23/2025

Erectile Dysfunction Risk with Perindopril

Introduction to Perindopril and Erectile Dysfunction

  • The American Heart Association recommends that ACE inhibitors like perindopril are among the least likely antihypertensive drug classes to impair erectile function and may even be protective compared to diuretics or beta-blockers 1, 2

Evidence from Clinical Trials

  • The European Society of Cardiology notes that the EUROPA trial demonstrated significant cardiovascular benefits of perindopril 8 mg daily in 12,218 patients over 4.2 years without reporting erectile dysfunction as a notable adverse effect 3

Comparative Risk Among Antihypertensive Classes

  • The American College of Cardiology states that thiazide diuretics carry the highest risk of erectile dysfunction, with a 17.1% incidence of erection problems at 24 months versus 8.1% with placebo in the TOMHS trial 2
  • The American Heart Association guidelines indicate that ACE inhibitors show no increased incidence of erectile dysfunction compared to placebo in multiple controlled trials 2

Mechanistic Considerations and Clinical Context

  • The European Society of Cardiology suggests that the protective effect of ACE inhibitors relates to their favorable impact on endothelial function rather than impairing it 1
  • The American Urological Association notes that alpha-blockers may offer dual benefits for both hypertension and BPH while showing the lowest rates of erectile dysfunction among all antihypertensive classes 2

Management Algorithm if ED Develops

  • The American College of Cardiology recommends evaluating other contributing factors first, such as progression of underlying vascular disease, uncontrolled diabetes, depression, or psychological factors, before attributing ED to perindopril 2
  • The American Heart Association guidelines state that PDE5 inhibitors can be safely combined with ACE inhibitors as first-line ED treatment 1
  • The American College of Cardiology notes that if other causes are excluded, consider switching to an ARB, which has similarly low ED risk 1, 2

Critical Safety Point

  • The American College of Cardiology and American Heart Association guidelines explicitly state that phosphodiesterase-5 inhibitors make drug class distinctions for erectile dysfunction less relevant, since effective ED treatment is now available that can be safely combined with virtually all antihypertensives except nitrates 1